A Phase II trial of the cyclin-dependent kinase inhibitor Flavopiridol in patients with previously untreated stage IV non-small cell lung cancerSHAPIRO, Geoffrey I; SUPKO, Jeffrey G; PATTERSON, Angus et al.Clinical cancer research. 2001, Vol 7, Num 6, pp 1590-1599, issn 1078-0432Article

Phase ii clinical trial of chemotherapy-naive patients ≥ 70 years of age treated with erlotinib for advanced non-small-cell lung cancerJACKMAN, David M; YEAP, Beow Y; FREIDLIN, Boris et al.Journal of clinical oncology. 2007, Vol 25, Num 7, pp 760-766, issn 0732-183X, 7 p.Article

Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, 'Iressa') on an expanded access studyJÄNNE, Pasi A; GURUBHAGAVATULA, Sarada; YEAP, Beow Y et al.Lung cancer. 2004, Vol 44, Num 2, pp 221-230, issn 0169-5002, 10 p.Article

Erlotinib Plus Bevacizumab in Previously Treated Patients With Malignant Pleural MesotheliomaJACKMAN, David M; KINDLER, Hedy L; YEAP, Beow Y et al.Cancer. 2008, Vol 113, Num 4, pp 808-814, issn 0008-543X, 7 p.Article

A phase II study of weekly Paclitaxel in elderly patients with advanced non-small cell lung cancerFIDIAS, Panos; SUPKO, Jeffrey G; SKARIN, Arthur et al.Clinical cancer research. 2001, Vol 7, Num 12, pp 3942-3949, issn 1078-0432Article

Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: A Phase I studyWIRTH, Lori J; LUCCA, Joan; LUKANICH, Jeanne M et al.Clinical cancer research. 2003, Vol 9, Num 5, pp 1698-1704, issn 1078-0432, 7 p.Article

Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinomaSALGIA, Ravi; LYNCH, Thomas; LUKANICH, Jean et al.Journal of clinical oncology. 2003, Vol 21, Num 4, pp 624-630, issn 0732-183X, 7 p.Article